In addition, CFZ induced growth inhibition and apoptosis through inhibiting the NF-κB signaling pathways in mantle cell lymphoma (25), and co-administration abrogated NF-κB activity in vorinostat-treated granta cells and HF-4B cells (23). The gene discussed is NFKB1; the disease is hydrops fetalis.